Top compounds associated with response to ZBTB18


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.16 2e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.15 4e-07
Download CSV